Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;78(6):816-825.
doi: 10.1053/j.ajkd.2020.11.032. Epub 2021 Aug 2.

Changes in Body Composition, Muscle Strength, and Fat Distribution Following Kidney Transplantation

Thomas Dienemann  1 , Susan L Ziolkowski  2 , Shaun Bender  3 , Simin Goral  4 , Jin Long  5 , Joshua F Baker  6 , Justine Shults  7 , Babette S Zemel  8 , Peter P Reese  9 , F Perry Wilson  10 , Mary B Leonard  11
Affiliations

Changes in Body Composition, Muscle Strength, and Fat Distribution Following Kidney Transplantation

Thomas Dienemann et al. Am J Kidney Dis. 2021 Dec.

Abstract

Rationale & objective: Low muscle mass relative to fat mass (relative sarcopenia) has been associated with mortality and disability but has not been examined after kidney transplantation. We studied how measures of body composition change after receipt of a kidney allograft.

Study design: Prospective longitudinal cohort study.

Setting & participants: 60 kidney transplant recipients, aged 20-60 years, at the University of Pennsylvania.

Exposure: Kidney transplantation.

Outcome: Dual-energy x-ray absorptiometry measures of fat mass index (FMI) and appendicular lean mass index (ALMI, representing muscle mass), computed tomography measures of muscle density (low density represents increased intramuscular adipose tissue), dynamometer measures of leg muscle strength, and physical activity. ALMI relative to FMI (ALMFMI) is an established index of relative sarcopenia.

Analytical approach: Measures expressed as age, sex, and race-specific z scores for transplant recipients were compared with 327 healthy controls. Regression models were used to identify correlates of change in outcome z scores and compare transplant recipients with controls.

Results: At transplantation, ALMI, ALMIFMI, muscle strength, and muscle density z scores were lower versus controls (all P≤0.001). Transplant recipients received glucocorticoids throughout. The prevalence of obesity increased from 18% to 45%. Although ALMI increased after transplantation (P<0.001) and was comparable with the controls from 6 months onward, gains were outpaced by increases in FMI, resulting in persistent ALMIFMI deficits (mean z score of-0.31 at 24 months; P=0.02 vs controls). Muscle density improved after transplantation despite gains in FMI (P=0.02). Muscle strength relative to ALMI also improved (P=0.04) but remained low compared with controls (P=0.01). Exercise increased in the early months after transplantation (P<0.05) but remained lower than controls (P = 0.02).

Limitations: Lack of muscle biopsies precluded assessment of muscle histology and metabolism.

Conclusions: The 2-year interval after kidney transplantation was characterized by gains in muscle mass and strength that were outpaced by gains in fat mass, resulting in persistent relative sarcopenia.

Keywords: Body mass index (BMI); body weight; dual-energy x-ray absorptiometry (DXA); end-stage renal disease (ESRD); fat mass; intramuscular adipose tissue; kidney transplantation; muscle strength; obesity; physical activity; posttransplant weight gain; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure: The authors declare that they have no relevant financial interests.

Figures

Figure 1.
Figure 1.
Baseline Z-scores in Kidney Transplant Recipients
Figure 2.
Figure 2.
Change in Body Composition Z-scores from baseline after Transplantation
Figure 3.
Figure 3.
Change in Muscle Density and Stength Z-scores from baseline after Transplantation
See this image and copyright information in PMC

References

    1. Cheema B, Abas H, Smith B, et al. Investigation of skeletal muscle quantity and quality in end-stage renal disease. Nephrology (Carlton, Vic.). 2010;15(4): 454–463 - PubMed
    1. Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK, Kent-Braun JA. Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney international. 2003;63(1): 291–297. - PubMed
    1. Johansen KL, Dalrymple LS, Delgado C, et al. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. Journal of the American Society of Nephrology : JASN. 2014;25(2): 381–389. - PMC - PubMed
    1. Lewis MI, Fournier M, Wang H, et al. Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients. Journal of applied physiology (Bethesda, Md. : 1985). 2012;112(1): 72–78. - PMC - PubMed
    1. Ziolkowski SL, Long J, Baker JF, Simard JF, Chertow GM, Leonard MB. Sarcopenia, Relative Sarcopenia and Excess Adposity in Chronic Kidney Disease. J Cachexia Sarcopenia Muscle. 2018;3(1): 1–11.

Publication types